A 12 Month Study to Evaluate the Efficacy and Safety of Once-Daily Instillation of Combination Glaucoma Therapy in Patients With Open-Angle Glaucoma or Ocular Hypertension.

This study has been completed.

First Received: April 4, 2006 Last Updated: May 31, 2006 History of Changes

Sponsored by:	Alcon Research
Information provided by:	Alcon Research
ClinicalTrials.gov Identifier:	NCT00311389

Purpose

To compare the intraocular pressure(IOP)-lowering efficacy of morning or evening instillations of a combination IOP-lowering therapy in patients with open-angle glaucoma or ocular hypertension.

Condition	Intervention	Phase
Glaucoma, Open-Angle Ocular Hypertension	Drug: Combination IOP Lowering Therapy	Phase II

Genetics Home Reference related topics: early-onset glaucoma

MedlinePlus related topics: Glaucoma High Blood Pressure

U.S. FDA Resources

Study Type:	Interventional
Study Design:	Treatment, Randomized, Double-Blind, Active Control, Parallel Assignment, Safety/Efficacy Study
Official Title:	A 12 Month Study to Evaluate the Efficacy and Safety of Once-Daily Instillation of Combination Glaucoma Therapy in Patients With Open-Angle Glaucoma or Ocular Hypertension.

Eligibility

Ages Eligible for Study:	18 Years and older
Genders Eligible for Study:	Both
Accepts Healthy Volunteers:	No

Criteria

Adult patients of any race and either sex with open angle glaucoma or ocular hypertension.

Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00311389

Locations

Belgium
European Facilitiies
Puurs, Belgium

Sponsors and Collaborators

Alcon Research

More Information

No publications provided

Study ID Numbers:	C-02-28
Study First Received:	April 4, 2006
Last Updated:	May 31, 2006
ClinicalTrials.gov Identifier:	NCT00311389 History of Changes
Health Authority:	United States: Food and Drug Administration

Keywords provided by Alcon Research:

Glaucoma
POAG
OAG
OHT

Study placed in the following topic categories:

Glaucoma
Eye Diseases
Glaucoma, Open-Angle

Vascular Diseases
Hypertension
Ocular Hypertension

Additional relevant MeSH terms:

Glaucoma
Eye Diseases
Glaucoma, Open-Angle
Vascular Diseases

Cardiovascular Diseases
Ocular Hypertension
Hypertension

ClinicalTrials.gov processed this record on May 07, 2009